|
Business Description and Going Concern (Details Narrative 2) (USD $)
|
0 Months Ended | ||
|---|---|---|---|
|
Mar. 01, 2012
|
May 16, 2011
Aero Pharmaceuticals, Inc. ("Aero")
|
Sep. 21, 2011
Aero Pharmaceuticals, Inc. ("Aero")
|
|
| Acquisition Date | May 16, 2011 | ||
| Number of shares issued for acquisition (in shares) | 8,331,396 | ||
| Purchase price | $ 2,000,000 | ||
| Accounting method | Acquisition Method | ||
| Share price (in dollars per share) | $ 1 | $ 0.5 |
| X | ||||||||||
|
- Definition
The total cost of the acquired entity including the cash paid to shareholders of acquired entities, fair value of debt and equity securities issued to shareholders of acquired entities, the fair value of the liabilities assumed, and direct costs of the acquisition. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
A description of the accounting for each transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in the business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Price of a single share of a number of saleable stocks of a company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|